N-3 PUFA supplementation benefits microglial responses to myelin pathology

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Songela ^a   Zhang, Haiyue ^a,c   Pu, Hongjian ^a,b   Wang, Guohua ^a,b   Li, Wenjin ^a   Leak, Rehana K ^d   Chen, Jun ^a,b   Liou, Anthony K ^a   Hu, Xiaoming ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d DUQUESNE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL; C57BL MOUSE; CELL CULTURE; DIET SUPPLEMENTATION; DRUG EFFECTS; MALE; MICROGLIA; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE;

ADMINISTRATION, ORAL; ANIMALS; CELLS, CULTURED; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; MALE; MICE, INBRED C57BL; MICROGLIA; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE;

EID: 84927645086     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07458     Document Type: Article

References (35)

1. Kutzelnigg, A. et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128, 2705-2712 (2005).
2. Politis, M. et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 79, 523-530 (2012).
3. Kotter, M. R., Zhao, C., van Rooijen, N. & Franklin, R. J. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiology of disease 18, 166-175 (2005).
4. Napoli, I. & Neumann, H. Protective effects of microglia inmultiple sclerosis. Exp Neurol 225, 24-28 (2010).
5. Boven, L. A. et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129, 517-526 (2006).
6. Miron, V. E. et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nature neuroscience 16, 1211-1218 (2013).
7. Mikita, J. et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 17, 2-15 (2011).
8. Hu, X. et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke; a journal of cerebral circulation 43, 3063-3070 (2012).
9. Wang, G. et al.Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab 33, 1864-1874 (2013).
10. Kigerl, K. A. et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29, 13435-13444 (2009).
11. Huang, W. et al. Identification of Distinct Monocyte Phenotypes and Correlation With Circulating Cytokine Profiles in Acute Response to Spinal Cord Injury: A Pilot Study. PM & R: the journal of injury, function, and rehabilitation 6, 332-334 (2013).
12. Calon, F. et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633-645 (2004).
13. Lim, G. P. et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25, 3032-3040 (2005).
14. Green, K. N. et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via amechanism involving presenilin 1 levels. J Neurosci 27, 4385-4395 (2007).
15. Bousquet, M. et al. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. Faseb J 22, 1213-1225 (2008).
16. Virtanen, J. K. et al. Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the Cardiovascular Health Study. J Am Heart Assoc 2, e000305 (2013).
17. Bowman, G. L. et al. Plasma omega-3 PUFA and white matter mediated executive decline in older adults. Front Aging Neurosci 5, 92 (2013).
18. Weinstock-Guttman, B. et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 73, 397-404 (2005).
19. Jelinek, G. A. et al. Association of fish consumption and Omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis. Int J Neurosci 123, 792-800 (2013).
20. Kong, W., Yen, J. H. & Ganea, D. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav Immun 25, 872-882 (2011).
21. Perry, V. H., Nicoll, J. A. & Holmes, C. Microglia in neurodegenerative disease. Nat Rev Neurol 6, 193-201 (2010).
22. Pinteaux-Jones, F. et al. Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J Neurochem 106, 442-454 (2008).
23. Liu, Y. et al. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J Neurosci 26, 12904-12913 (2006).
24. Ajmone-Cat, M. et al. Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells. J Neurosci Res 90, 575-587 (2012).
25. Belayev, L., Khoutorova, L., Atkins, K. D. & Bazan, N. G. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 40, 3121-3126 (2009).
26. Berman, D. R., Mozurkewich, E., Liu, Y. & Barks, J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am J Obstet Gynecol 200, 305 e301-306 (2009).
27. Calon, F. & Cole, G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 77, 287-293 (2007).
28. Ebert, S. et al. Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration. Journal of neurochemistry 110, 1863-1875 (2009).
29. Zhang, W., Hu, X., Yang, W., Gao, Y. & Chen, J. Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions. Stroke 41, 2341-2347 (2010).
30. Hjorth, E. et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer's diseaserelated amyloid-beta42 by human microglia and decrease inflammatory markers. J Alzheimers Dis 35, 697-713 (2013).
31. Pu, H. et al. Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J Cereb Blood Flow Metab 33, 1474-1484 (2013).
32. Jaudszus, A. et al. Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells. J Lipid Res 54, 923-935 (2013).
33. Rapoport, S. I. & Igarashi, M. Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? Prostaglandins Leukot Essent Fatty Acids 81, 119-123 (2009).
34. Hu, X. et al. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J Immunol 181, 7194-7204 (2008).
35. Norton, W. T. & Poduslo, S. E. Myelination in rat brain: method of myelin isolation. J Neurochem 21, 749-757 (1973).